Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Restructuring Costs: 2015-2020

Historic Restructuring Costs for Avadel Pharmaceuticals (AVDL) over the last 5 years, with Sep 2020 value amounting to -$69,000.

  • Avadel Pharmaceuticals' Restructuring Costs fell 103.70% to -$69,000 in Q3 2020 from the same period last year, while for Sep 2020 it was -$428,000, marking a year-over-year decrease of 126.46%. This contributed to the annual value of $3.3 million for FY2020, which is 293.73% up from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Restructuring Costs stood at -$69,000 for Q3 2020, which was down 107.52% from $918,000 recorded in Q2 2020.
  • Avadel Pharmaceuticals' Restructuring Costs' 5-year high stood at $23.9 million during Q2 2016, with a 5-year trough of -$13.2 million in Q2 2017.
  • For the 3-year period, Avadel Pharmaceuticals' Restructuring Costs averaged around -$1.6 million, with its median value being $918,000 (2020).
  • Within the past 5 years, the most significant YoY rise in Avadel Pharmaceuticals' Restructuring Costs was 142.58% (2018), while the steepest drop was 510.40% (2018).
  • Avadel Pharmaceuticals' Restructuring Costs (Quarterly) stood at -$3.7 million in 2016, then surged by 74.81% to -$933,000 in 2017, then slumped by 510.40% to -$5.7 million in 2018, then surged by 34.06% to -$3.8 million in 2019, then tumbled by 103.70% to -$69,000 in 2020.
  • Its Restructuring Costs was -$69,000 in Q3 2020, compared to $918,000 in Q2 2020 and $2.5 million in Q1 2020.